AIM ImmunoTech Inc. Quarterly Common Stock, Shares, Issued from Q4 2010 to Q2 2024

Taxonomy & unit
us-gaap: shares
Description
Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.
Summary
AIM ImmunoTech Inc. quarterly Common Stock, Shares, Issued history and growth rate from Q4 2010 to Q2 2024.
  • AIM ImmunoTech Inc. Common Stock, Shares, Issued for the quarter ending June 30, 2024 was 57.1M shares, a 18% increase year-over-year.
Common Stock, Shares, Issued, Quarterly (shares)
Common Stock, Shares, Issued, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q2 2024 57.1M +8.72M +18% Jun 30, 2024 10-Q 2024-08-14
Q1 2024 50.3M +1.84M +3.81% Mar 31, 2024 10-Q 2024-05-15
Q4 2023 49.1M +1.02M +2.12% Dec 31, 2023 10-Q 2024-08-14
Q3 2023 48.8M +715K +1.49% Sep 30, 2023 10-Q 2023-11-14
Q2 2023 48.4M +371K +0.77% Jun 30, 2023 10-Q 2023-08-14
Q1 2023 48.4M +413K +0.86% Mar 31, 2023 10-Q 2023-05-15
Q4 2022 48.1M +89.6K +0.19% Dec 31, 2022 10-K 2024-04-01
Q3 2022 48.1M +234K +0.49% Sep 30, 2022 10-Q 2022-11-14
Q2 2022 48M Jun 30, 2022 10-Q 2022-08-15
Q1 2022 48M +162K +0.34% Mar 31, 2022 10-Q 2022-05-13
Q4 2021 48M +5.84M +13.9% Dec 31, 2021 10-Q 2022-11-14
Q3 2021 47.8M +7.16M +17.6% Sep 30, 2021 10-Q 2021-11-15
Q1 2021 47.8M +19.8M +70.5% Mar 31, 2021 10-Q 2021-08-16
Q4 2020 42.2M +31.8M +306% Dec 31, 2020 10-K 2022-03-31
Q3 2020 40.7M +34.6M +567% Sep 30, 2020 10-Q 2020-11-12
Q2 2020 34.3M +32M +1446% Jun 30, 2020 10-Q 2020-08-14
Q1 2020 28.1M -34.8M -55.4% Mar 31, 2020 10-Q/A 2020-05-14
Q4 2019 10.4M +9.28M +838% Dec 31, 2019 10-K 2021-03-31
Q3 2019 6.1M -41.9M -87.3% Sep 30, 2019 10-Q 2019-11-14
Q2 2019 2.21M -44.6M -95.3% Jun 30, 2019 10-Q 2019-08-14
Q1 2019 62.9M +23.7M +60.4% Mar 31, 2019 10-Q 2019-05-15
Q4 2018 1.11M -31.8M -96.6% Dec 31, 2018 10-K 2020-03-30
Q3 2018 48M +16.9M +54.3% Sep 30, 2018 10-Q 2018-11-14
Q2 2018 46.8M +17.9M +61.7% Jun 30, 2018 10-Q 2018-08-14
Q1 2018 39.2M +13M +49.8% Mar 31, 2018 10-Q 2018-05-15
Q4 2017 32.9M +8.68M +35.9% Dec 31, 2017 10-K 2019-04-01
Q3 2017 31.1M +6.97M +28.9% Sep 30, 2017 10-Q 2017-11-14
Q2 2017 29M -220M -88.4% Jun 30, 2017 10-Q 2017-08-14
Q1 2017 26.2M -221M -89.4% Mar 31, 2017 10-Q 2017-05-15
Q4 2016 24.2M +3.57M +17.3% Dec 31, 2016 10-K 2018-03-30
Q3 2016 24.1M -223M -90.3% Sep 30, 2016 10-Q 2016-11-14
Q2 2016 249M +3.35M +1.36% Jun 30, 2016 10-Q 2016-08-15
Q1 2016 248M +21.8M +9.67% Mar 31, 2016 10-Q 2016-05-16
Q4 2015 20.6M -183M -89.9% Dec 31, 2015 10-K 2017-03-31
Q3 2015 248M +53.8M +27.8% Sep 30, 2015 10-Q 2015-11-16
Q2 2015 245M +56M +29.5% Jun 30, 2015 10-Q 2015-08-12
Q1 2015 226M +42.5M +23.2% Mar 31, 2015 10-Q 2015-05-12
Q4 2014 204M +35.3M +21% Dec 31, 2014 10-K 2016-03-29
Q3 2014 194M +26.2M +15.6% Sep 30, 2014 10-Q 2014-11-07
Q2 2014 189M +22.3M +13.3% Jun 30, 2014 10-Q 2014-08-08
Q1 2014 183M +16.2M +9.7% Mar 31, 2014 10-Q 2014-05-09
Q4 2013 169M +2.17M +1.3% Dec 31, 2013 10-K 2015-03-19
Q3 2013 168M +20M +13.6% Sep 30, 2013 10-Q 2013-11-08
Q2 2013 167M +31M +22.8% Jun 30, 2013 10-Q 2013-08-09
Q1 2013 167M +31.2M +23% Mar 31, 2013 10-Q 2013-05-08
Q4 2012 166M +30.8M +22.7% Dec 31, 2012 10-K 2014-03-14
Q3 2012 148M +12M +8.83% Sep 30, 2012 10-Q 2012-11-02
Q2 2012 136M +762K +0.56% Jun 30, 2012 10-Q 2012-08-08
Q1 2012 136M Mar 31, 2012 10-Q 2012-05-07
Q4 2011 136M +401K +0.3% Dec 31, 2011 10-K 2013-03-18
Q3 2011 136M Sep 30, 2011 10-Q 2011-11-09
Q2 2011 135M Jun 30, 2011 10-Q 2011-08-05
Q4 2010 135M Dec 31, 2010 10-K 2012-03-14
* An asterisk sign (*) next to the value indicates that the value is likely invalid.